Hester Biosciences has informed that, as per Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended from time to time), a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 9 May 2025, to consider the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2025 and to consider the declaration of dividend, if any, on the equity shares of the Company for the financial year 2024-25.
The above information is a part of company’s filings submitted to BSE.
